BICX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 15:09):

Stats
Today's Volume	7 500.00
Average Volume	940.00
Market Cap	10.94M
EPS	$0 ( 2024-04-01 )
Next earnings date	( $0 ) 2024-05-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.820
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Galligan Joseph J	Buy	5 566	Common Stock, par value $0.001
2024-01-02	Galligan Joseph J	Buy	6 173	Common Stock, par value $0.001
2024-03-28	Granier Brady James	Buy	16 698	Stock Option
2024-03-28	Murthy Harsha	Buy	5 566	Common Stock, par value $0.001
2024-01-02	Murthy Harsha	Buy	6 173	Common Stock, par value $0.001

INSIDER POWER
100.00
Last 98 transactions
Buy: 888 470 \| Sell: 0

BioCorRx Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioCorRx Inc. Financials

Annual	2023
Revenue:	$89 160.00
Gross Profit:	$-146 762 (-164.61 %)
EPS:	$-0.450

FY	2023
Revenue:	$89 160.00
Gross Profit:	$-146 762 (-164.61 %)
EPS:	$-0.450

FY	2022
Revenue:	$213 841
Gross Profit:	$198 562 (92.85 %)
EPS:	$-0.610

FY	2021
Revenue:	$48 272.00
Gross Profit:	$42 391.00 (87.82 %)
EPS:	$-0.810

Financial Reports:

No articles found.

BioCorRx Inc.

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.